/People

Mathai Mammen

Investor

Advisor at Foresite Capital

Find your path to Mathai

Sign up to see every warm intro you have to Mathai

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Mathai. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Mathai Mammen has advised Foresite Capital since 2019 and is Chairman and CEO of Parabilis Medicines (formerly FogPharma). He previously served on the Executive Committee of Johnson & Johnson as EVP of J&J Pharmaceuticals R&D and was senior vice president at Merck Research Laboratories, leading research across cardiovascular, metabolic, renal, oncology/immuno-oncology and immunology areas. Earlier he co-founded and led R&D at Theravance, which he built on science from his PhD at Harvard University, and spun out Innoviva and Theravance Biopharma.

Invests in

Biotech

Investments

Board seats

Parabilis Medicines

Per the firm's website.

Colleagues at Foresite Capital

Frequently asked questions

Who is Mathai Mammen?
Mathai Mammen has advised Foresite Capital since 2019 and is Chairman and CEO of Parabilis Medicines (formerly FogPharma). He previously served on the Executive Committee of Johnson & Johnson as EVP of J&J Pharmaceuticals R&D and was senior vice president at Merck Research Laboratories, leading research across cardiovascular, metabolic, renal, oncology/immuno-oncology and immunology areas. Earlier he co-founded and led R&D at Theravance, which he built on science from his PhD at Harvard University, and spun out Innoviva and Theravance Biopharma.
Where does Mathai Mammen work?
Mathai Mammen is Advisor at Foresite Capital.
What does Mathai Mammen invest in?
Mathai Mammen invests in Biotech.
What boards does Mathai Mammen sit on?
Mathai Mammen holds tracked board seats at Parabilis Medicines.

About this profile. Compiled from public sources — Foresite Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights